Practical Strategies for Determining the Duration of Anticoagulation in Patients Diagnosed with VTE
![]() |
Practical Strategies for Determining the Duration of Anticoagulation in Patients Diagnosed with VTE CME, CNE, CE Jori May, MD; Stephan Moll, MD; and Paul Lewis, MD, FAAFP, ABPM-CI, CPE, CPHIMS |
|
Release Date: April 26, 2024 Expiration Date: April 26, 2025 |
||
In this accredited activity, a panel of experts in hematology/VTE and primary care address the critical question of the duration of anticoagulation in a patient who has experienced a DVT or PE. Faculty will outline the factors that will guide the nonspecialist in determining a patient’s risk of recurrence and identifying whether the patient should undergo anticoagulation of short- or long-term duration. Through the use of tools that consider not only the patient’s current and ongoing risk factors, but that provide guidance on which patients should receive D-dimer or thrombophilia testing, participants will increase their ability to answer questions that include, “Is my patient at risk for recurrence of their VTE?”, “Should I use a D-dimer test or test the patient for thrombophilia?” and “Once I have the test results, do I know what to do with them?” Provided by MediCom Worldwide, Inc.This activity is supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance. |
||
Begin, Earn CreditView Only, No Credit | ||